OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2023
(4)
2022
(2)
2020
(2)
2026
(1)
2024
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Solubility vs Dissolution in Physiological Bicarbonate Buffer.
Not available
S-EPMC11116206
|
biostudies-literature
Cite
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product.
Not available
S-EPMC9965879
|
biostudies-literature
Cite
In Vitro Evaluation of Enteric-Coated HPMC Capsules-Effect of Formulation Factors on Product Performance.
Not available
S-EPMC7465055
|
biostudies-literature
Cite
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
Not available
S-EPMC10505723
|
biostudies-literature
Cite
Tumor-infiltrating CCR2
+
inflammatory monocytes counteract specific immunotherapy.
Not available
S-EPMC10577317
|
biostudies-literature
Cite
Dithranol as novel co-adjuvant for non-invasive dermal vaccination.
Not available
S-EPMC9509335
|
biostudies-literature
Cite
Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA.
Not available
S-EPMC7563888
|
biostudies-literature
Cite
Advanced Quality and Comparability Assessment of mRNA-Loaded Lipid Nanoparticles: Absolute Size Distribution Profiles and Structure from AF4-Coupled Light and X-ray Scattering Measurements.
Not available
S-EPMC12937060
|
biostudies-literature
Cite
Quantitative size-resolved characterization of mRNA nanoparticles by in-line coupling of asymmetrical-flow field-flow fractionation with small angle X-ray scattering.
Not available
S-EPMC10516866
|
biostudies-literature
Cite
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
Not available
S-EPMC9016006
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets